RET receptor tyrosine kinase architecture, assemblies, and activation
Endocrine-Related Cancer · 01.04.2026 · 33 (4)
DOI: 10.1530/erc-25-0322 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Endocrine-Related Cancer, online erschienen am 01.04.2026. Verfasst von Mia Zol-Hanlon und 1 weiteren Autor:innen. Beteiligte Einrichtung: Signalling and Structural Biology Laboratory, Francis Crick Institute, London, United Kingdom. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-ret. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Cancer Research UK.
Abstract (Originalsprache)
Among the 58 human receptor tyrosine kinases that are known, only the RET (REarrangement during Transfection) receptor contains cadherin-like domains in its extracellular portion. This multidomain extracellular module contains a binding site for a family of five related heterodimeric ligands. Each heterodimer comprises a secreted glial cell line-derived neurotrophic factor (GDNF) family ligand (GFL) and a membrane-anchored co-receptor GFR⍺ (GDNF family receptor alpha). Once a GFL–GFR⍺ ligand is bound to RET, this stimulates the activation of the receptor through tyrosine-based autophosphorylation. This mini review explores how the shape and architecture of RET encode a flexible GFL–GFR⍺-binding site, summarising recent progress in understanding RET structure. It then discusses current views on how distinct assemblies of GFL–GFR⍺–RET receptor complexes are able to activate the intrinsic RET tyrosine kinase function to relay intracellular signals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Signalling and Structural Biology Laboratory, Francis Crick Institute, London, United Kingdom.
- Institute of Structural and Molecular Biology, School of Natural Sciences, Birkbeck College, London, United Kingdom.
ORCID-Profile: Mia Zol-Hanlon, Neil Q McDonald
Förderung
- Cancer Research UK
Zitieren
APA
Zol-Hanlon, M., & McDonald, N. Q. (2026). RET receptor tyrosine kinase architecture, assemblies, and activation. Endocrine-Related Cancer, 33(4). https://doi.org/10.1530/erc-25-0322
Vancouver
Zol-Hanlon M, McDonald NQ. RET receptor tyrosine kinase architecture, assemblies, and activation. Endocrine-Related Cancer. 2026;33(4). doi:10.1530/erc-25-0322
BibTeX
@article{ZolHanlon2026,
author = {Zol-Hanlon, Mia and McDonald, Neil Q},
title = {RET receptor tyrosine kinase architecture, assemblies, and activation},
journal = {Endocrine-Related Cancer},
year = {2026},
volume = {33},
number = {4},
doi = {10.1530/erc-25-0322}
}
EUVIMED